Form 4: Labcorp EVP Mark S. Schroeder Reports Stock Transactions

Mark S. Schroeder, EVP, President Diagnostics & COO of Labcorp Holdings Inc., reports acquisition and disposal of common stock and derivative securities.

Summary

• Mark S. Schroeder, an executive at Labcorp Holdings Inc., filed a Form 4 detailing changes in beneficial ownership.
• On February 11, 2025, Schroeder acquired 473 shares of common stock through the vesting of restricted stock units.
• Also on February 11, 2025, Schroeder disposed of 134 shares of common stock to satisfy tax withholding obligations at a price of $245.14 per share.
• Schroeder also acquired 7,300 non-qualified stock options exercisable beginning February 11, 2026, and 2,420 restricted stock units vesting in three equal annual installments beginning February 11, 2026.
• Following these transactions, Schroeder beneficially owns 6,396.1426 shares of common stock directly, 7,300 non-qualified stock options, and 5,061 restricted stock units.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing of stock transactions. The acquisition of stock options and restricted stock units is a positive sign, but the disposal of shares for tax obligations is a neutral event.

Positives

• The acquisition of stock options and restricted stock units indicates confidence in the company's future performance.
• The vesting of restricted stock units suggests that performance targets have been met.

Negatives

• The disposal of shares to cover tax obligations, while routine, slightly reduces Schroeder's direct holdings.

Future Outlook

The vesting schedule of the restricted stock units and the exercisability of the stock options suggest a long-term incentive structure for the executive.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies and are often viewed as a signal of management's confidence in the company's prospects. This filing is a routine disclosure required by the SEC.

Comparison to Industry Standards

• Executive compensation packages, including stock options and restricted stock units, are standard practice among publicly traded companies like Labcorp.
• Companies such as Quest Diagnostics (DGX) and Mayo Clinic Laboratories also utilize similar equity-based compensation to align executive interests with shareholder value.
• The vesting schedules and terms of these equity grants are generally in line with industry norms, designed to incentivize long-term performance and retention.

Stakeholder Impact

• The transactions have a minor impact on shareholders, reflecting routine executive compensation adjustments.
• Employees may view the executive's stock ownership as a sign of commitment to the company's success.

Key Dates

Keywords

Form 4, beneficial ownership, stock options, restricted stock units, Labcorp, Schroeder, executive compensation, stock transactions